Medable provides a digital platform that simplifies the process of conducting clinical trials in the healthcare sector. Its main features include tools for onboarding participants, collecting data, sending study notifications, and offering real-time reporting. This platform digitizes the entire clinical trial process, making it easier for pharmaceutical companies and other organizations to gather high-quality data needed to validate their drugs or treatments. Medable stands out from competitors with its user-friendly design, scalability, and a strong decentralized clinical trial (DCT) network, which allows trials to be conducted remotely. The company aims to support the growing DCT market, which is projected to exceed $12 billion by 2030, by providing a platform that is accessible in over 60 countries and 120 languages.